Janssen issues recall for three lots of oral contraceptives

Janssen Pharmaceuticals has launched a voluntary recall of one lot of Ortho-Novum 1/35 (norethindrone/ethinyl estradiol) tablets and two lots of Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol) tablets to the pharmacy level.

Janssen Pharmaceuticals has launched a voluntary recall of one lot of Ortho-Novum 1/35 (norethindrone/ethinyl estradiol) tablets and two lots of Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol) tablets to the pharmacy level. According to the company, the patient information inside the affected packages does not include the correct instructions for the Veridate dispenser. Janssen stressed that the Ortho-Novum product itself "remains safe and effective for use with the appropriate dispenser instructions. Women should continue to take the 21 "active" pills (with hormones) (peach for ORTHO-NOVUM 1/35; white, light-peach and peach for ORTHO-NOVUM 7/7/7) for three weeks, followed by the one week of green "reminder" pills (without hormones). Further information